These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8699555)

  • 21. Heroin body-packing and naloxone.
    Vahabzadeh M; Banagozar Mohammadi A
    Lancet; 2019 Mar; 393(10177):e35. PubMed ID: 30910307
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
    Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
    Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prehospital treatment of patients with i.v. heroin overdose: what are we treating?
    Pedersen CB; Steentoft A; Worm K; Sprehn M; Mogensen T; Sørensen MB
    Prehosp Disaster Med; 1997; 12(2):163-6. PubMed ID: 10187003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport.
    Vilke GM; Sloane C; Smith AM; Chan TC
    Acad Emerg Med; 2003 Aug; 10(8):893-6. PubMed ID: 12896894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone for administration by peers in cases of heroin overdose.
    Lenton SR; Dietze PM; Degenhardt L; Darke S; Butler TG
    Med J Aust; 2009 Oct; 191(8):469. PubMed ID: 19835548
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergency naloxone for heroin overdose: naloxone is not the only opioid antagonist.
    Brewer C
    BMJ; 2006 Oct; 333(7571):754-5. PubMed ID: 17023477
    [No Abstract]   [Full Text] [Related]  

  • 27. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.
    Maxwell S; Bigg D; Stanczykiewicz K; Carlberg-Racich S
    J Addict Dis; 2006; 25(3):89-96. PubMed ID: 16956873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catch and release: evaluating the safety of non-fatal heroin overdose management in the out-of-hospital environment.
    Stam NC; Pilgrim JL; Drummer OH; Smith K; Gerostamoulos D
    Clin Toxicol (Phila); 2018 Nov; 56(11):1135-1142. PubMed ID: 29873588
    [No Abstract]   [Full Text] [Related]  

  • 29. The distribution of naloxone to heroin users.
    Darke S; Hall W
    Addiction; 1997 Sep; 92(9):1195-9. PubMed ID: 9374020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergency naloxone for heroin overdose.
    Strang J; Kelleher M; Best D; Mayet S; Manning V
    BMJ; 2006 Sep; 333(7569):614-5. PubMed ID: 16990298
    [No Abstract]   [Full Text] [Related]  

  • 31. Intranasal naloxone for the treatment of suspected heroin overdose.
    Kerr D; Dietze P; Kelly AM
    Addiction; 2008 Mar; 103(3):379-86. PubMed ID: 18269360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute unilateral edema of the lung in patient with heroin overdose and treated with intravenous naloxone].
    Navarro Reynés A; Pujol A; Priu Baixeras R; Balanzó Fernández X
    Med Clin (Barc); 1990 Apr; 94(16):637. PubMed ID: 2381249
    [No Abstract]   [Full Text] [Related]  

  • 33. No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone.
    Jones JD; Campbell A; Metz VE; Comer SD
    Addict Behav; 2017 Aug; 71():104-106. PubMed ID: 28325710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Summaries for patients: naloxone for heroin overdose reversal.
    Ann Intern Med; 2013 Jan; 158(1):I-30. PubMed ID: 23277911
    [No Abstract]   [Full Text] [Related]  

  • 35. An Innovative Model for Naloxone Use Within an OTP Setting: A Prospective Cohort Study.
    Katzman JG; Takeda MY; Bhatt SR; Moya Balasch M; Greenberg N; Yonas H
    J Addict Med; 2018; 12(2):113-118. PubMed ID: 29227321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.
    Cantwell K; Dietze P; Flander L
    Resuscitation; 2005 Jun; 65(3):315-9. PubMed ID: 15919568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Naloxone-induced pulmonary edema. Case report with review of the literature and critical evaluation].
    Lassen CL; Zink W; Wiese CH; Graf BM; Wiesenack C
    Anaesthesist; 2012 Feb; 61(2):129-36. PubMed ID: 22354400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.
    Coffin PO; Sullivan SD
    Ann Intern Med; 2013 Jan; 158(1):1-9. PubMed ID: 23277895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prehospital Naloxone Administration as a Public Health Surveillance Tool: A Retrospective Validation Study.
    Lindstrom HA; Clemency BM; Snyder R; Consiglio JD; May PR; Moscati RM
    Prehosp Disaster Med; 2015 Aug; 30(4):385-9. PubMed ID: 26061280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caution with naloxone use in asthmatic patients.
    Allegretti PJ; Bzdusek JS; Leonard J
    Am J Emerg Med; 2006 Jul; 24(4):515-6. PubMed ID: 16787825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.